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The First Case of X-linked Alpha-thalassemia/Mental Retardation 
(ATR-X) Syndrome in Korea
Mutation of the ATRX gene leads to X-linked alpha-thalassemia/mental retardation (ATR-X) 
syndrome and several other X-linked mental retardation syndromes. We report the first 
case of ATR-X syndrome documented here in Korea. A 32-month-old boy came in with 
irritability and fever. He showed dysmorphic features, mental retardation and epilepsy, so 
ATR-X syndrome was considered. Hemoglobin H inclusions in red blood cells supported the 
diagnosis and genetic studies confirmed it. Mutation analysis for our patient showed a 
point mutation of thymine to cytosine on the 9th exon in the ATRX gene, indicating that 
Trp(C), the 220th amino acid, was replaced by Ser(R). Furthermore, we investigated the 
same mutation in family members, and his mother and two sisters were found to be 
carriers.
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The rare association between α-thalassemia and mental retar-
dation was first recognized in 1981 by Weatherall and colleagues 
(1). Then, in 1995, in a case of α-thalassemia/mental retardation 
(ATR-X) syndrome, mutations in the ATRX gene locus Xq13.3 
were first reported (2). Since then, studies have identified 127 
mutations in this gene in patients with ATR-X syndrome (3-7). 
While the cellular function of ATRX has not yet been fully eluci-
dated, the characteristics of the syndrome suggest that ATRX 
probably functions as part of a chromatin remodeling complex 
to regulate the transcription of a discrete set of target genes, of 
which α-globin genes involved in brain development are the 
best characterized example (8-10). 
  Although there have been many studies and case reports of 
this syndrome and the ATRX gene all over the world, no case 
has been reported in Korea until now. We encountered the first 
Korean case of ATR-X syndrome and reported it.
CASE DESCRIPTION
A 32-month-old boy was admitted to our hospital with two days 
of irritability and fever. He was born with a birth weight of 2.9 kg 
by normal spontaneous vaginal delivery at 40 weeks gestation 
to a healthy 28-yr-old G3P2 mother. His delivery was non-event-
ful, but there was flexion deformity of both his middle fingers, 
so he was transferred to our hospital and underwent many di-
agnostic tests and physical therapies in January, 2002. He showed 
mild general hypotonia in that his cry was weak, and he sucked 
poorly during early infancy. He had epileptic seizures 6 times 
since the age of 15 months despite taking anti-epileptic medica-
tions. A diagnosis of mental retardation complicated by epilep-
sy was made, and his development was noted to be markedly 
delayed. He raised his head at age 7 months, sat up at 26 months, 
and had not yet acquired the ability to stand. He had a flat and 
mid-hypoplastic face with prognathism, narrow and upward 
slanting palpebral fissures with hypertelorism, low-set ears, a 
small crashed nose, widely spaced incisors, carp-like mouth, 
and round back (Fig. 1). He demonstrated repeated stereotyped 
behavior like hitting his chin with his palm; this behavior was 
often associated with emotional outbursts. 
  Soon after admission, a generalized tonic-clonic type seizure 
was started and lasted approximately one hour; at that time his 
vital signs were as follows: blood pressure 100/60 mmHg, pulse 
rate 138 bpm, respiration rate 32 bpm, and body temperature 
38.5°C. Mild throat injection was seen, but other systemic exam-
inations were normal. On neurologic exam, mental status was 
alert, all cranial nerve exams were normal, and muscle tone in 
both extremities were decreased to grade IV/IV bilaterally but 
all deep tendon reflexes were physiologic. There was no spas-
ticity or pathologic reflex. Sensory functions were normal and 
meningeal irritation signs were absent.
  Initial laboratory investigations revealed: hemoglobin 12.7 g/
dL, platelet count 374,000/µL and white blood cell count 11,780/ Yun KW, et al.  •  ATR-X Syndrome in Korea
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µL. The C-reactive protein was slightly elevated at 19.0 mg/dL 
on the day of admission and returned to normal 3 days later. 
Urinalysis was normal. All microbiologic studies were negative. 
A sleep electroencephalogram revealed intermittent high-am-
plitude slow wave discharges from the temporo-occipital area, 
representing mild cerebral dysfunction. On radiologic evalua-
tion, spine radiography revealed mild scoliosis. An echocardio-
gram was normal.
  The characteristic facial features and mental retardation of 
the patient led us to consider ATR-X syndrome; thus, peripheral 
RBCs were screened for hemoglobin H (HbH) inclusion bodies. 
HbH inclusions were detected under the microscope in 1.1% of 
brilliant cresyl blue stained RBCs, consistent with the diagnosis 
of ATR-X syndrome (Fig. 2). The patient’s father, mother and two 
sisters were all given the same test; only his mother and eldest 
sister had the same findings. We performed gene analysis to con-
firm the diagnosis of ATR-X syndrome. Genomic DNA from the 
peripheral blood of our patient and his 4 family members was 
extracted with the Wizard
® Genomic DNA Purification Kit (Pro-
mega, Madison, WI, USA) and used as a template for amplifica-
tion of the ATRX gene. Polymerase chain reaction (PCR) was 
separated into three parts and carried out with sequence-spe-
cific oligonucleotide primers containing 20 known major muta-
tion sites (Table 1, Figs. 3, 4). PCR amplification using each prim-
er was conducted with premixture kit (PreMix
TM-Top, Bioneer 
Inc., Seoul, Korea). Cycling conditions were one cycle at 95°C 
for 5 min, followed by 35 cycles of 95°C for 30 sec, at an anneal-
ing temperature adjusted to each primer’s (Tm) for 30 sec, 72°C 
for 30 sec, followed by one cycle at 72°C for 7 min. For direct se-
quencing, the PCR products were purified using a PCR clean-
up system offered by Promega. DNA sequencing was performed 




Fig. 3. Sequences of ATRX gene amplified by primer pair for mutation analysis. Under­
lined sequences in each box present exon regions of ATRX gene. Blue, pink and yellow 
color boxes present sequences of primer pairs. Putative mutation site is indicated as 
red boxes. (A) amplified sequences by ATRX A primer pairs, (B) amplified sequences 
by ATRX B primer pairs, (C) amplified sequences by ATRX C.
A B
Fig. 1. Facials features of the patient. Our patient expressed the typical facial pheno­
type comprising epicanthus, midface hypoplasia, flat nasal bridge, small triangular 
nose with anteverted nostrils, carp­shaped mouth with full lips, and dental diastema 
at age 6 months (A) and 3 yr (B).
B
C A
Fig. 2. Photomicrograph of the peripheral blood of our case with ATR­X syndrome. It 
shows cells containing HbH inclusions in our patient (A), and also his mother (B) and 
eldest sister (C). 
Table 1. Characterization and PCR conditions of primers for mutation analysis of ATRX gene
Primers Location* Sequences Size (bp) PCR conditions Tm
Number of  
cycles
ATRX A 108112/108221   5´   AATAATAGCCACTCCTTTCTCC   3´
5´   TTTGTACGTCTATTTTCCCCACTA   3´
283 bioneer premix. 49 35
ATRX B 112384/112606 5´   ATTAAATTTCCCCTTCCTCTT   3´
5´   AAAGATTATTCCCAACAAAACTC   3´
372 bioneer premix. 48 35
ATRX C 112034/112101 5´   TCAGGTGGTGTGCGGAAGGT   3´
5´   CAACAAAGGCTCTGGGTGACA   3´
164 bioneer premix. 58 35
*Accession no. Z84487.Yun KW, et al.  •  ATR-X Syndrome in Korea
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as those used for template generation, the BigDye terminator 
cycle sequencing ready reaction kit (Applied Biosystems, Foster 
City, CA, USA), and automatic sequencer ABI Prism 3730 XL 
DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Se-
quence data were assembled and compared to that of a previ-
ously reported ATRX sequence from accession number Z84487 
using the DNAstar software (DNASTAR Inc., Madison, WI, USA).
  Mutation analysis for our patient showed a point mutation 
on the 9th exon in the ATRX gene of thymine to cytosine so that 
Trp(C), the 220th amino acid, was replaced by Ser(R) (Fig. 5). 
This missense mutation was reported by Gibbons in 1997 (8). 




Fig. 4. PCR amplification by ATRX primers. M, size marker; 1, patients’s father; 2, 
patients’s mother; 3, ATRX patient, 4, patients’s sister 1; 5, patients’s sister 2.
A C B
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Fig. 5. Sequence of mutation region detected by ATRX B reverse primer. Sequencing conducted under BigDyeTM terminator cycling conditions. The reacted products purified 
using ethanol precipitation and run using Automatic sequencer 3730xl. (A) ATRX patient’s father, (B) ATRX patient’s mother, (C) ATRX patient, (D) ATRX patient’s sister 1, (E) 
ATRX patient’s sister 2.
and his mother and two sisters were found to be carriers. 
DISCUSSION
The X-Linked α-thalassemia mental retardation syndrome is a 
serious recessive disorder resulting from mutations in the ATRX 
gene, mapping in Xq13.3 and coding for a protein containing 
the signature motif of the SNF2 family of ATPases. Members of 
this protein family are thought to act generally as part of large 
multi-protein complexes and impart on those complexes the 
ability to utilize the energy of ATP hydrolysis to remodel the 
structure of chromatin and thereby regulate protein/DNA in-
teractions (11).
  This disease is very rare, probably with an incidence of less 
than 1/100,000 live-born males (11). So far, 173 patients have 
been reported. Affected males present with severe mental retar-
dation, a typical facial appearance, microcephaly, urogenital 
anomalies, and an atypical form of α-thalassemia. Pregnancy is 
usually uneventful, proceeds to term, and, in 90% of cases, birth 
weight is normal. Affected neonates usually have marked hypo-
tonia and associated feeding difficulties. In early childhood, all 
milestones are delayed. As the affected individuals grow older, 
there is often a tendency toward spasticity. Seizures occur in 
approximately one third of cases. A number of patients have re-
portedly had jerking movements that are not associated with 
epileptiform activity on EEG. Brain imaging studies frequently 
show no abnormality, although mild cerebral atrophy or agen-
esis of the corpus callosum may be seen. The distinctive facial 
traits are most readily recognized in early childhood: the frontal 
hair is often upswept; there is telecanthus, epicanthic folds, mid-
face hypoplasia, and a small, triangular, upturned nose. The up-
per lip is tented and the lower lip is full and everted, giving the 
mouth a “carp-like” appearance. The frontal incisors are fre-
quently widely spaced, and the tongue protrudes. Genital ab-
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normalities are seen in 80% of these children. A wide range of 
relatively mild skeletal abnormalities have been noted. Recur-
rent vomiting or regurgitation, sometimes treated by fundopli-
cation, is a common finding. The tendency to aspiration is com-
monly implicated as a cause of death in early childhood. Con-
stipation is common and in some individuals is a major prob-
lem to manage. A wide range of cardiac and renal abnormali-
ties also has been noted. There is considerable variation in the 
hematologic manifestations associated with ATRX mutations 
(11). A number of families have been identified in which some 
or all of the affected members have no signs of α-thalassemia; 
despite lack of these signs, however, diagnosis of α-thalassemia 
requires only a simple investigation. 
  Female carriers of ATRX mutations do not have a distinctive 
phenotype. They are intellectually normal and have no consis-
tent physical manifestations, because they show preferential 
inactivation of the mutated X-chromosome. Rare cells with HbH 
inclusions may be found in approximately one fourth of obli-
gate carriers (12). In our case, there were HbH inclusions in 2 of 
3 carriers. But recently, there have been some cases of females 
with ATRX mutations with phenotypical abnormalities. Wada 
et al. (13) reported a carrier mother who showed non-skewed 
X-inactivation with moderate mental retardation. Furthermore, 
Badens et al. (14) described a 4-yr-old girl with typical features 
of ATR-X syndrome, carrying the recurrent R246C mutation of 
ATRX. They showed that her pattern of X-inactivation was total-
ly skewed and that her active X chromosome, which harbors the 
ATRX mutation, was maternally inherited. That was the first re-
port of ATR-X syndrome in a female patient. Fortunately, none 
of our female carriers had phenotypical abnormalities.
  We report the first Korean case of ATR-X syndrome in a 32- 
month-old boy. Now, we can consider ATR-X syndrome in a 
young male child with characteristic facial features and neuro-
logic abnormalities of unknown etiology, and get simple screen-
ing test for HbH inclusions so that adequate and early manage-
ment should be started.
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